IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed May 9, 2024 · 10-Q · 39 days after period end · 0000950170-24-056910
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$8.56M | -$7.53M | -$6.15M | -$2.36M |
| EPS Diluted | -$0.20 | -$0.30 | -$0.33 | -$0.82 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 9, 2024 · 39 d after period end
